Association between Exposure to Nevirapine and Reduced Liver Fibrosis Progression in Patients with HIV and Hepatitis C Virus Coinfection | Zendy

Juan Berenguer | Zendy; José M. Bellón | Zendy; Pilar Miralles | Zendy; Estela Álvarez | Zendy; Inmaculada Castillo | Zendy; J. Cosin | Zendy; Jesús LópezHerce | Zendy; Matilde SánchezConde | Zendy; B. Padilla | Zendy; Salvador Resino | Zendy

Open Access

Association between Exposure to Nevirapine and Reduced Liver Fibrosis Progression in Patients with HIV and Hepatitis C Virus Coinfection

Author(s) -

Juan Berenguer,

José M. Bellón,

Pilar Miralles,

Estela Álvarez,

Inmaculada Castillo,

J. Cosin,

Jesús LópezHerce,

Matilde SánchezConde,

B. Padilla,

Salvador Resino

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/524080

Subject(s) - nevirapine , medicine , efavirenz , coinfection , odds ratio , hepatitis c virus , gastroenterology , hepatitis c , reverse transcriptase inhibitor , fibrosis , confidence interval , immunology , viral load , sida , viral disease , virus , antiretroviral therapy

We analyzed the effect of exposure to nonnucleoside reverse-transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) on the progression of liver fibrosis in patients with human immunodeficiency virus (HIV) and hepatitis C virus coinfection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research